ADVATE is a medicine used to prevent and control bleeding in adults and children with hemophilia A. ADVATE is not used to treat von Willebrand disease.
With ADVATE®, look to the Takeda FVIII family to be with you wherever life takes you.
*In clinical trials, ADVATE has demonstrated the ability to help patients prevent bleeding episodes using a prophylaxis regimen.
For people with hemophilia A, a factor VIII deficiency bleeding disorder, ADVATE has a legacy of treatment experience and provides clinically proven bleed protection.*1,2
Learn moreADVATE has been proven effective for prophylaxis, on-demand, and surgical use in preventing bleeding episodes for children and adults and has an established safety profile.1,3
Explore ADVATE
safety information
Flexible dosing
options
ADVATE has multiple potencies that may fit your factor VIII replacement treatment needs.1
ADVATE support
Takeda has a variety of resources and programs to help you every step of the way with your treatment on ADVATE.
References
- ADVATE Prescribing Information.
- Data on file. Takeda Pharmaceutical Company Limited. 2018.
- Shapiro AD, Schoenig-Diesing C, Silvati-Fidell L, Wong WY, Romanov V. Integrated analysis of safety data from 12 clinical interventional studies of plasma- and albumin-free recombinant factor VIII (rAHF-PFM) in haemophilia A. Haemophilia. 2015;21(6):791-798.
- Valentino LA. Considerations in individualizing prophylaxis in patients with haemophilia A. Haemophilia. 2014;20(5):607-615.
Selected Important Risk Information
Do not use ADVATE if you are allergic to mice or hamsters or are allergic to any ingredients in ADVATE. Tell your HCP if you are pregnant or breastfeeding because ADVATE may not be right for you.
